Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT05431257
Title Azacitidine in Combination With Low Dose Intensity Venetoclax in Patients With AML Incl. Explorative AML Profiling (LD-VenEx)
Acronym LD-VenEx
Recruitment Recruiting
Gender both
Phase Phase II
Variant Requirements No
Sponsors Rigshospitalet, Denmark
Indications
Therapies
Age Groups: adult | senior
Covered Countries DNK


No variant requirements are available.